Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Detection of AmpC beta-lactamase production by enterobacteria has been problematic. Contrary to ESBLs, no specific guidelines are available for detection and confirmation of AmpC production by clinical relevant microorganisms. Moreover, some bacterial species may produce inducible AmpC beta-lactamases that can be easily overlooked by routine susceptibility tests. We reported here a new test based on the strong inducible effect of imipenem on AmpC genes and the consequent antagonism with ceftazidime. This test is very simple and proved to be helpful in detecting AmpC-inducible enzymes among several species of clinical isolates. © 2007 by The Brazilian Journal of Infectious Diseases and Contexto Publishing. All rights reserved.

Cite

CITATION STYLE

APA

Cantarelli, V. V., Inamine, E., Brodt, T. C. Z., Secchi, C., Cavalcante, B. C., & Pereira, F. de S. (2007). Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae. Brazilian Journal of Infectious Diseases, 11(2), 237–239. https://doi.org/10.1590/S1413-86702007000200014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free